Profile: Advanced Life Sciences Inc. has a pipeline of clinical & preclinical product candidates for our own discovery programs in the areas of infectious disease, oncology, and respiratory disease. Our product cethromycin is an antibiotic that recently demonstrated positive phase III results for the treatment of community acquired pneumonia (CAP). We are developing ALS-357 that has demonstrated specific anti-tumor activity against malignant melanoma. It has a unique mechanism of action that disrupts mitochondrial membrane function and is associated with the intrinsic, mitochondria-mediated pathway of apoptosis.